Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M. +11 more·2005·Science
DOI 10.1126/science.1113694

Cited by (213)

Items 101–200 of 213

  1. Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
    Dorostkar, Mario M., Zou, Chengyu, Blazquez-Llorca, Lidia, Herms, Jochen · 2015 · Acta Neuropathologica
  2. Soluble forms of tau are toxic in Alzheimer's disease
    Kopeikina, Katherine, Hyman, Bradley, Spires-Jones, Tara · 2012 · Translational Neuroscience
  3. Mechanisms of Protein Seeding in Neurodegenerative Diseases
    Walker, Lary C., Diamond, Marc I., Duff, Karen E., Hyman, Bradley T. · 2013 · JAMA Neurology
  4. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections
    Iba, Michiyo, McBride, Jennifer D., Guo, Jing L., Zhang, Bin, Trojanowski, John Q., Lee, Virginia M.-Y. · 2015 · Acta Neuropathologica
  5. Dendritic Spine Pathology in Neurodegenerative Diseases
    Herms, Jochen, Dorostkar, Mario M. · 2016 · Annual Review of Pathology: Mechanisms of Disease
  6. Mouse Models of Alzheimer’s Disease
    Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
  7. Protective effects and mechanisms of sirtuins in the nervous system
    Zhang, Feng, Wang, Suping, Gan, Li, Vosler, Peter S., Gao, Yanqin, Zigmond, Michael J., Chen, Jun · 2011 · Progress in Neurobiology
  8. A role for tau at the synapse in Alzheimer’s disease pathogenesis
    Pooler, Amy M., Noble, Wendy, Hanger, Diane P. · 2014 · Neuropharmacology
  9. Nanotechnology—novel therapeutics for CNS disorders
    Srikanth, Maya, Kessler, John A. · 2012 · Nature Reviews Neurology
  10. Caspase-2 cleavage of tau reversibly impairs memory
    Zhao, Xiaohui, Kotilinek, Linda A, Smith, Benjamin, Hlynialuk, Chris, Zahs, Kathleen, Ramsden, Martin, Cleary, James, Ashe, Karen H · 2016 · Nature Medicine
  11. Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis
    Meier, Shelby, Bell, Michelle, Lyons, Danielle N., Rodriguez-Rivera, Jennifer, Ingram, Alexandria, Fontaine, Sarah N., Mechas, Elizabeth, Chen, Jing, Wolozin, Benjamin, LeVine, Harry et al. · 2016 · The Journal of Neuroscience
  12. Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples
    Gillespie, Anna K., Jones, Emily A., Lin, Yuan-Hung, Karlsson, Mattias P., Kay, Kenneth, Yoon, Seo Yeon, Tong, Leslie M., Nova, Philip, Carr, Jessie S., Frank, Loren M. et al. · 2016 · Neuron
  13. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease
    Shukla, Varsha, Skuntz, Susan, Pant, Harish C. · 2012 · Archives of Medical Research
  14. Pathological Tau Disrupts Ongoing Network Activity
    Menkes-Caspi, Noa, Yamin, Hagar G., Kellner, Vered, Spires-Jones, Tara L., Cohen, Dana, Stern, Edward A. · 2015 · Neuron
  15. Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.
    Kitazawa, Masashi, Medeiros, Rodrigo, M. LaFerla, Frank · 2012 · Current Pharmaceutical Design
  16. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
    Jiang, Lulu, Lin, Weiwei, Zhang, Cheng, Ash, Peter E.A., Verma, Mamta, Kwan, Julian, van Vliet, Emily, Yang, Zhuo, Cruz, Anna Lourdes, Boudeau, Samantha et al. · 2021 · Molecular Cell
  17. Alzheimer disease pathology as a host response
    Castellani, Rudy J., Lee, Hyoung-gon, Zhu, Xiongwei, Perry, George, Smith, Mark A. · 2008 · Journal of Neuropathology & Experimental Neurology
  18. Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons
    Quintanilla, Rodrigo A., Matthews-Roberson, Tori A., Dolan, Philip J., Johnson, Gail V.W. · 2009 · Journal of Biological Chemistry
  19. Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
    Guerrero-Muñoz, Marcos J., Gerson, Julia, Castillo-Carranza, Diana L. · 2015 · Frontiers in Cellular Neuroscience
  20. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
    Hastings, Nicholas B., Wang, Xiaohai, Song, Lixin, Butts, Brent D., Grotz, Diane, Hargreaves, Richard, Fred Hess, J., Hong, Kwok-Lam Karen, Huang, Cathy Ruey-Ruey, Hyde, Lynn et al. · 2017 · Molecular Neurodegeneration
  21. Time to test antibacterial therapy in Alzheimer’s disease
    Panza, Francesco, Lozupone, Madia, Solfrizzi, Vincenzo, Watling, Mark, Imbimbo, Bruno P · 2019 · Brain
  22. Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
    Basheer, Neha, Smolek, Tomáš, Hassan, Imtaiyaz, Liu, Fei, Iqbal, Khalid, Zilka, Norbert, Novak, Petr · 2023 · Molecular Psychiatry
  23. Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
    Castillo-Carranza, Diana L., Guerrero-Muñoz, Marcos J., Sengupta, Urmi, Hernandez, Caterina, Barrett, Alan D.T., Dineley, Kelly, Kayed, Rakez · 2015 · The Journal of Neuroscience
  24. RNA binding proteins co-localize with small tau inclusions in tauopathy
    Maziuk, Brandon F., Apicco, Daniel J., Cruz, Anna Lourdes, Jiang, Lulu, Ash, Peter E. A., da Rocha, Edroaldo Lummertz, Zhang, Cheng, Yu, Wai Haung, Leszyk, John, Abisambra, Jose F. et al. · 2018 · Acta Neuropathologica Communications
  25. Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
    Bi, Mian, Ittner, Arne, Ke, Yazi D., Götz, Jürgen, Ittner, Lars M. · 2011 · PLoS ONE
  26. A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration
    Karsten, Stanislav L., Sang, Tzu-Kang, Gehman, Lauren T., Chatterjee, Shreyasi, Liu, Jiankai, Lawless, George M., Sengupta, Soma, Berry, Robert W., Pomakian, Justine, Oh, Hyun S. et al. · 2006 · Neuron
  27. Stem cell models of Alzheimer’s disease: progress and challenges
    Arber, Charles, Lovejoy, Christopher, Wray, Selina · 2017 · Alzheimer's Research & Therapy
  28. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
    Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Ris, Laurence, Wang, Peng, Villers, Agnès, Peeraer, Eve, Buist, Arjan, Terwel, Dick, Baatsen, Peter, Oyelami, Tutu et al. · 2015 · Acta Neuropathologica
  29. <i>In Vivo</i>Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders
    Maeda, Jun, Zhang, Ming-Rong, Okauchi, Takashi, Ji, Bin, Ono, Maiko, Hattori, Satoko, Kumata, Katsushi, Iwata, Nobuhisa, Saido, Takaomi C., Trojanowski, John Q. et al. · 2011 · The Journal of Neuroscience
  30. Differential effect of three‐repeat and four‐repeat tau on mitochondrial axonal transport
    Stoothoff, Will, Jones, Phillip B., Spires‐Jones, Tara L., Joyner, Daniel, Chhabra, Ekta, Bercury, Kathryn, Fan, Zhanyun, Xie, Hong, Bacskai, Brian, Edd, Jon et al. · 2009 · Journal of Neurochemistry
  31. Pre‐synaptic C‐terminal truncated tau is released from cortical synapses in Alzheimer's disease
    Sokolow, Sophie, Henkins, Kristen M., Bilousova, Tina, Gonzalez, Bianca, Vinters, Harry V., Miller, Carol A., Cornwell, Lindsey, Poon, Wayne W., Gylys, Karen H. · 2015 · Journal of Neurochemistry
  32. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
    Wegmann, Susanne, Maury, Eduardo A, Kirk, Molly J, Saqran, Lubna, Roe, Allyson, DeVos, Sarah L, Nicholls, Samantha, Fan, Zhanyun, Takeda, Shuko, Cagsal‐Getkin, Ozge et al. · 2015 · The EMBO Journal
  33. Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
    Pan, Yijun, Nicolazzo, Joseph A. · 2018 · Advanced Drug Delivery Reviews
  34. <i>In Vivo</i> Imaging Reveals Dissociation between Caspase Activation and Acute Neuronal Death in Tangle-Bearing Neurons
    Spires-Jones, Tara L., de Calignon, Alix, Matsui, Toshifumi, Zehr, Cindy, Pitstick, Rose, Wu, Hai-Yan, Osetek, Jennifer D., Jones, Phillip B., Bacskai, Brian J., Feany, Mel B. et al. · 2008 · The Journal of Neuroscience
  35. Is Alzheimer’s a disease of the white matter?
    Sachdev, Perminder S., Zhuang, Lin, Braidy, Nady, Wen, Wei · 2013 · Current Opinion in Psychiatry
  36. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease
    Roberts, Malcolm, Sevastou, Ioanna, Imaizumi, Yoichi, Mistry, Kavita, Talma, Sonia, Dey, Madhurima, Gartlon, Jane, Ochiai, Hiroshi, Zhou, Zhi, Akasofu, Shigeru et al. · 2020 · Acta Neuropathologica Communications
  37. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice
    Leroy, Karelle, Bretteville, Alexis, Schindowski, Katharina, Gilissen, Emmanuel, Authelet, Michèle, De Decker, Robert, Yilmaz, Zehra, Buée, Luc, Brion, Jean-Pierre · 2007 · The American Journal of Pathology
  38. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
    Van der Jeugd, Ann, Hochgräfe, Katja, Ahmed, Tariq, Decker, Jochen M., Sydow, Astrid, Hofmann, Anne, Wu, Dan, Messing, Lars, Balschun, Detlef, D’Hooge, Rudi et al. · 2012 · Acta Neuropathologica
  39. The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease
    Merino-Serrais, Paula, Benavides-Piccione, Ruth, Blazquez-Llorca, Lidia, Kastanauskaite, Asta, Rábano, Alberto, Avila, Jesús, DeFelipe, Javier · 2013 · Brain
  40. RETRACTED: Soluble α-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
    Larson, Megan E., Sherman, Mathew A., Greimel, Susan, Kuskowski, Michael, Schneider, Julie A., Bennett, David A., Lesné, Sylvain E. · 2012 · The Journal of Neuroscience · Retracted
  41. Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-β, Wild-Type Tau, and R406W Tau
    Tackenberg, Christian, Brandt, Roland · 2009 · The Journal of Neuroscience
  42. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
    Nobuhara, Chloe K., DeVos, Sarah L., Commins, Caitlin, Wegmann, Susanne, Moore, Benjamin D., Roe, Allyson D., Costantino, Isabel, Frosch, Matthew P., Pitstick, Rose, Carlson, George A. et al. · 2017 · The American Journal of Pathology
  43. Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
    Barini, Erica, Antico, Odetta, Zhao, Yingjun, Asta, Francesco, Tucci, Valter, Catelani, Tiziano, Marotta, Roberto, Xu, Huaxi, Gasparini, Laura · 2016 · Molecular Neurodegeneration
  44. Tau isoform composition influences rate and extent of filament formation
    Zhong, Qi, Congdon, Erin E., Nagaraja, Haikady N., Kuret, Jeff · 2012 · Journal of Biological Chemistry
  45. Tau drives translational selectivity by interacting with ribosomal proteins
    Koren, Shon A., Hamm, Matthew J., Meier, Shelby E., Weiss, Blaine E., Nation, Grant K., Chishti, Emad A., Arango, Juan Pablo, Chen, Jing, Zhu, Haining, Blalock, Eric M. et al. · 2019 · Acta Neuropathologica
  46. Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer’s disease model
    Polydoro, Manuela, Dzhala, Volodymyr I., Pooler, Amy M., Nicholls, Samantha B., McKinney, A. Patrick, Sanchez, Laura, Pitstick, Rose, Carlson, George A., Staley, Kevin J., Spires-Jones, Tara L. et al. · 2014 · Acta Neuropathologica
  47. The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
    Cárdenas-Aguayo, María del Carmen, Gómez-Virgilio, Laura, DeRosa, Steven, Meraz-Ríos, Marco Antonio · 2014 · ACS Chemical Neuroscience
  48. Seed‐competent high‐molecular‐weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients
    Takeda, Shuko, Commins, Caitlin, DeVos, Sarah L., Nobuhara, Chloe K., Wegmann, Susanne, Roe, Allyson D., Costantino, Isabel, Fan, Zhanyun, Nicholls, Samantha B., Sherman, Alexis E. et al. · 2016 · Annals of Neurology
  49. Disease modifying therapy for AD?<sup>1</sup>
    Golde, Todd E. · 2006 · Journal of Neurochemistry
  50. Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M. · 2008 · Journal of Alzheimer's Disease
  51. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
    Nash, Kevin R., Lee, Daniel C., Hunt, Jerry B., Morganti, Josh M., Selenica, Maj-Linda, Moran, Peter, Reid, Patrick, Brownlow, Milene, Guang-Yu Yang, Clement, Savalia, Miloni et al. · 2013 · Neurobiology of Aging
  52. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
    Castellani, Rudy J., Perry, George · 2019 · Journal of Alzheimer’s Disease
  53. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy
    Ljungberg, M. Cecilia, Ali, Yousuf O., Zhu, Jie, Wu, Chia-Shan, Oka, Kazuhiro, Zhai, R. Grace, Lu, Hui-Chen · 2012 · Human Molecular Genetics
  54. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
    DeVos, Sarah L, Corjuc, Bianca T, Commins, Caitlin, Dujardin, Simon, Bannon, Riley N, Corjuc, Diana, Moore, Benjamin D, Bennett, Rachel E, Jorfi, Mehdi, Gonzales, Jose A et al. · 2018 · Brain
  55. Strain Background Influences Neurotoxicity and Behavioral Abnormalities in Mice Expressing the Tetracycline Transactivator
    Han, H. J., Allen, C. C., Buchovecky, C. M., Yetman, M. J., Born, H. A., Marin, M. A., Rodgers, S. P., Song, B. J., Lu, H.-C., Justice, M. J. et al. · 2012 · Journal of Neuroscience
  56. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity
    Ando, Kanae, Maruko-Otake, Akiko, Ohtake, Yosuke, Hayashishita, Motoki, Sekiya, Michiko, Iijima, Koichi M. · 2016 · PLOS Genetics
  57. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy, Karelle, Ando, Kunie, Héraud, Céline, Yilmaz, Zehra, Authelet, Michèle, Boeynaems, Jean-Marie, Buée, Luc, De Decker, Robert, Brion, Jean-Pierre · 2010 · Journal of Alzheimer's Disease
  58. Axonal degeneration in tauopathies: disease relevance and underlying mechanisms
    Kneynsberg, Andrew, Combs, Benjamin, Christensen, Kyle, Morfini, Gerardo, Kanaan, Nicholas M. · 2017 · Frontiers in Neuroscience
  59. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice
    Baker, Siân, Polanco, Juan Carlos, Götz, Jϋrgen · 2016 · Journal of Alzheimer's Disease
  60. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
    Gómez-Isla, Teresa, Frosch, Matthew P. · 2022 · Nature Reviews Neurology
  61. In vivo imaging of tau pathology using multi-parametric quantitative MRI
    Wells, J.A., O'Callaghan, J.M., Holmes, H.E., Powell, N.M., Johnson, R.A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X. et al. · 2015 · NeuroImage
  62. Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway
    Jiang, Shanya, Maphis, Nicole M., Binder, Jessica, Chisholm, Devon, Weston, Lea, Duran, Walter, Peterson, Crina, Zimmerman, Amber, Mandell, Michael A., Jett, Stephen D. et al. · 2021 · Cell Reports
  63. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
    Wang, Hong, Li, Yupeng, Ryder, John W., Hole, Justin T., Ebert, Philip J., Airey, David C., Qian, Hui-Rong, Logsdon, Benjamin, Fisher, Alice, Ahmed, Zeshan et al. · 2018 · Molecular Neurodegeneration
  64. Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer’s Disease
    Soeda, Yoshiyuki, Saito, Marino, Maeda, Sumihiro, Ishida, Kohki, Nakamura, Akira, Kojima, Shuichi, Takashima, Akihiko · 2019 · Journal of Alzheimer’s Disease
  65. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
    Pritchard, Susanne M., Dolan, Philip J., Vitkus, Alisa, Johnson, Gail V.W. · 2011 · Journal of Cellular and Molecular Medicine
  66. Targeting Aβ and tau in Alzheimer's disease, an early interim report
    Golde, Todd E., Petrucelli, Leonard, Lewis, Jada · 2010 · Experimental Neurology
  67. Soluble tau Species, Not Neurofibrillary Aggregates, Disrupt Neural System Integration in a tau Transgenic Model
    Fox, Leora M., William, Christopher M., Adamowicz, David H., Pitstick, Rose, Carlson, George A., Spires-Jones, Tara L., Hyman, Bradley T. · 2011 · Journal of Neuropathology &amp; Experimental Neurology
  68. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model
    Cook, Casey, Kang, Silvia S., Carlomagno, Yari, Lin, Wen-Lang, Yue, Mei, Kurti, Aishe, Shinohara, Mitsuru, Jansen-West, Karen, Perkerson, Emilie, Castanedes-Casey, Monica et al. · 2015 · Human Molecular Genetics
  69. Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy
    de Calignon, Alix, Spires-Jones, Tara L., Pitstick, Rose, Carlson, George A., Hyman, Bradley T. · 2009 · Journal of Neuropathology &amp; Experimental Neurology
  70. Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
    Klohs, Jan, Rudin, Markus, Shimshek, Derya R., Beckmann, Nicolau · 2014 · Frontiers in Aging Neuroscience
  71. Persistent repression of tau in the brain using engineered zinc finger protein transcription factors
    Wegmann, Susanne, DeVos, Sarah L., Zeitler, Bryan, Marlen, Kimberly, Bennett, Rachel E., Perez-Rando, Marta, MacKenzie, Danny, Yu, Qi, Commins, Caitlin, Bannon, Riley N. et al. · 2021 · Science Advances
  72. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
    van Dijk, Gertjan, van Heijningen, Steffen, Reijne, Aaffien C., Nyakas, Csaba, van der Zee, Eddy A., Eisel, Ulrich L. M. · 2015 · Frontiers in Neuroscience
  73. Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model
    Kim, YoungDoo, Choi, Hyunwoo, Lee, WonJae, Park, Hyejin, Kam, Tae-In, Hong, Se-hoon, Nah, Jihoon, Jung, Sunmin, Shin, Bora, Lee, Huikyong et al. · 2016 · Neurobiology of Disease
  74. The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease
    Golde, Todd E · 2009 · Molecular Neurodegeneration
  75. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
    Blackmore, Thomas, Meftah, Soraya, Murray, Tracey Karen, Craig, Peter James, Blockeel, Anthony, Phillips, Keith, Eastwood, Brian, O’Neill, Michael J., Marston, Hugh, Ahmed, Zeshan et al. · 2017 · Alzheimer's Research &amp; Therapy
  76. Microglia: Friend and foe in tauopathy
    Odfalk, Kristian F., Bieniek, Kevin F., Hopp, Sarah C. · 2022 · Progress in Neurobiology
  77. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers
    Singh, Ayush, Allen, Dyron, Fracassi, Anna, Tumurbaatar, Batbayar, Natarajan, Chandramouli, Scaduto, Pietro, Woltjer, Randy, Kayed, Rakez, Limon, Agenor, Krishnan, Balaji et al. · 2020 · Journal of Alzheimer's Disease
  78. Comparison of in vivo and ex vivo MRI for the detection of structural abnormalities in a mouse model of tauopathy
    Holmes, Holly E., Powell, Nick M., Ma, Da, Ismail, Ozama, Harrison, Ian F., Wells, Jack A., Colgan, Niall, O'Callaghan, James M., Johnson, Ross A., Murray, Tracey K. et al. · 2017 · Frontiers in Neuroinformatics
  79. Age-related loss of noradrenergic neurons in the brains of triple transgenic mice
    Manaye, Kebreten F., Mouton, Peter R., Xu, Guang, Drew, Amy, Lei, De-Liang, Sharma, Yukti, Rebeck, G. William, Turner, Scott · 2013 · AGE
  80. Tau acts as a mediator for<scp>A</scp>lzheimer's disease‐related synaptic deficits
    Liao, Dezhi, Miller, Eric C., Teravskis, Peter J. · 2014 · European Journal of Neuroscience
  81. Neurogenetics: Advancing the “Next-Generation” of Brain Research
    Zoghbi, Huda Y., Warren, Stephen T. · 2010 · Neuron
  82. Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
    Bittar, Alice, Sengupta, Urmi, Kayed, Rakez · 2018 · npj Vaccines
  83. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
    Yin, Xiaomin, Qiu, Yanyan, Zhao, Chenhao, Zhou, Zheng, Bao, Junze, Qian, Wei · 2021 · Medical Science Monitor
  84. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease
    Stancu, Ilie‐Cosmin, Ris, Laurence, Vasconcelos, Bruno, Marinangeli, Claudia, Goeminne, Léonie, Laporte, Vincent, Haylani, Laetitia E., Couturier, Julien, Schakman, Olivier, Gailly, Philippe et al. · 2014 · The FASEB Journal
  85. RETRACTED: Pharmacologic Inhibition of 5-Lipoxygenase Improves Memory, Rescues Synaptic Dysfunction, and Ameliorates Tau Pathology in a Transgenic Model of Tauopathy
    Giannopoulos, Phillip F., Chu, Jin, Sperow, Margaret, Li, Jian-Guo, Yu, W. Haung, Kirby, Lynn G., Abood, Mary, Praticò, Domenico · 2015 · Biological Psychiatry · Retracted
  86. NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
    Levenson, Jonathan M., Schroeter, Sally, Carroll, Jenna C., Cullen, Valerie, Asp, Eva, Proschitsky, Ming, Chung, Charlotte H.‐Y., Gilead, Sharon, Nadeem, Muhammad, Dodiya, Hemraj B. et al. · 2016 · Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions
  87. Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
    Pádua, Mafalda Soares, Guil-Guerrero, José L., Prates, José A. M., Lopes, Paula Alexandra · 2024 · International Journal of Molecular Sciences
  88. Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease
    Carosi, Julian M, Sargeant, Timothy J · 2023 · Autophagy
  89. Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin-6 in the TgCRND8 mouse model of amyloidosis
    Colon-Perez, Luis M., Ibanez, Kristen R., Suarez, Mallory, Torroella, Kristin, Acuna, Kelly, Ofori, Edward, Levites, Yona, Vaillancourt, David E., Golde, Todd E., Chakrabarty, Paramita et al. · 2019 · NeuroImage
  90. Chronic Effects of Mild Neurotrauma: Putting the Cart Before the Horse?
    Castellani, Rudy J., Perry, George, Iverson, Grant L. · 2015 · Journal of Neuropathology &amp; Experimental Neurology
  91. Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy
    Takashima, Akihiko · 2008 · Journal of Alzheimer s Disease
  92. Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
    Selenica, Maj-Linda B, Davtyan, Hayk, Housley, Steven B, Blair, Laura J, Gillies, Anne, Nordhues, Bryce A, Zhang, Bo, Liu, Joseph, Gestwicki, Jason E, Lee, Daniel C et al. · 2014 · Journal of Neuroinflammation
  93. All the Tau We Cannot See
    Hyman, Bradley · 2023 · Annual Review of Medicine
  94. N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
    Schlegel, Kerstin, Awwad, Khader, Heym, Roland G., Holzinger, David, Doell, Annika, Barghorn, Stefan, Jahn, Thomas R., Klein, Corinna, Mordashova, Yulia, Schulz, Michael et al. · 2019 · Acta Neuropathologica Communications
  95. Study the Longitudinal in vivo and Cross-Sectional ex vivo Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural Parcellation
    Ma, Da, Holmes, Holly E., Cardoso, Manuel J., Modat, Marc, Harrison, Ian F., Powell, Nick M., O’Callaghan, James M., Ismail, Ozama, Johnson, Ross A., O’Neill, Michael J. et al. · 2019 · Frontiers in Neuroscience
  96. Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice
    Vallés-Saiz, Laura, Ávila, Jesús, Hernández, Félix · 2023 · International Journal of Molecular Sciences
  97. Reelin proteolysis affects signaling related to normal synapse function and neurodegeneration
    Lussier, April L., Weeber, Edwin J., Rebeck, G. William · 2016 · Frontiers in Cellular Neuroscience
  98. Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses
    Rudinskiy, Nikita, Hawkes, Jonathan M, Wegmann, Susanne, Kuchibhotla, Kishore V, Muzikansky, Alona, Betensky, Rebecca A, Spires-Jones, Tara L, Hyman, Bradley T · 2014 · Acta Neuropathologica Communications
  99. The metamorphic nature of the Tau protein: dynamic flexibility comes at a cost
    Sabbagh, Jonathan J., Dickey, Chad A. · 2016 · Frontiers in Neuroscience
  100. Effect and mechanism of fuzhisan and donepezil on the sirtuin 1 pathway and amyloid precursor protein metabolism in PC12 cells
    GUO, PENG, WANG, DESHENG, WANG, XIAOMIN, FENG, HONGLIN, TANG, YING, SUN, RUIHONG, ZHENG, YAN, DONG, LIN, ZHAO, JIAYING, ZHANG, XIN et al. · 2016 · Molecular Medicine Reports